Risk of Lymphoma Associated With Combination Anti–Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease

Dr. Bruce Sands looks at the rate of non-Hodgkin's lymphoma in adult Crohn's disease patients who have received anti-TNF therapy, compared with that of a population-based registry and a populationof CD patients treated with immunomodulators.
Source: Clinical Gastroenterology and Hepatology - Category: Gastroenterology Authors: Source Type: podcasts